Supporting its role in the diseases of the nervous system, both MLKL and phosphorylated MLKL levels were found to be elevated in derived postmortem tissues of patients with Parkinson’s disease and samples from the brains of patients with Alzheimer’s disease [83,84,85]. This evidence concerns the gene MLKL and early-onset autosomal dominant Alzheimer disease.